Back to Search

ROBERT HERSHBERG, MD PHD

MD PHD

Clinical Genetics (M.D.) Physician

NPI: 1346444767Individual

Specialties, Licenses & Credentials

Clinical Genetics (M.D.) PhysicianPrimary

Medical Genetics — Clinical Genetics (M.D.)

Code: 207SG0201X

MD00031962(WA)

Research & Publications (20)

The epithelial cell cytoskeleton and intracellular trafficking. V. Polarized compartmentalization of antigen processing and Toll-like receptor signaling in intestinal epithelial cells.
PMID 12223342·Am J Physiol Gastrointest Liver Physiol·2002
6-review
General rules for optimal codon choice.
PMID 19593368·PLoS Genet·2009
8-other
High functional diversity in Mycobacterium tuberculosis driven by genetic drift and human demography.
PMID 19090620·PLoS Biol·2008
8-other
Selection on codon bias.
PMID 18983258·Annu Rev Genet·2008
6-review
Small RNAs encoded within genetic islands of Salmonella typhimurium show host-induced expression and role in virulence.
PMID 18267966·Nucleic Acids Res·2008
8-other
Ca2+-dependent calmodulin binding to FcRn affects immunoglobulin G transport in the transcytotic pathway.
PMID 18003977·Mol Biol Cell·2008
7-preclinical
Reduced selection leads to accelerated gene loss in Shigella.
PMID 17686180·Genome Biol·2007
8-other
Anti-flagellin (CBir1) phenotypic and genetic Crohn's disease associations.
PMID 17260364·Inflamm Bowel Dis·2007
8-other
Molecular approaches to the role of the microbiota in inflammatory bowel disease.
PMID 17057189·Ann N Y Acad Sci·2006
7-preclinical
Co-evolution of transcription factors and their targets depends on mode of regulation.
PMID 16859509·Genome Biol·2006
8-other
Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer.
PMID 16809734·J Clin Oncol·2006
3-trial
Combination immunotherapy with prostatic acid phosphatase pulsed antigen-presenting cells (provenge) plus bevacizumab in patients with serologic progression of prostate cancer after definitive local therapy.
PMID 16736512·Cancer·2006
3-trial
Serum immune responses predict rapid disease progression among children with Crohn's disease: immune responses predict disease progression.
PMID 16454844·Am J Gastroenterol·2006
4-observational
Chromosomal organization is shaped by the transcription regulatory network.
PMID 15734572·Trends Genet·2005
6-review
Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease.
PMID 15940634·Gastroenterology·2005
7-preclinical
A synthetic TLR4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease.
PMID 15879143·J Immunol·2005
7-preclinical
Synthetic toll-like receptor 4 agonists stimulate innate resistance to infectious challenge.
PMID 15845512·Infect Immun·2005
7-preclinical
Immunotherapy with autologous antigen presenting cells for the treatment of androgen independent prostate cancer.
PMID 15647927·World J Urol·2005
3-trial
Structure-activity relationship of synthetic toll-like receptor 4 agonists.
PMID 14570885·J Biol Chem·2004
7-preclinical
Bacterial flagellin is a dominant antigen in Crohn disease.
PMID 15124021·J Clin Invest·2004
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
1959 NE PACIFIC ST
SEATTLE, WA 98195

Location

Practice Location

1959 NE PACIFIC ST, SEATTLE, WA
(206) 616-2135

Quick Facts

NPI
1346444767
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile